Generated by DeepSeek V3.2| sildenafil | |
|---|---|
| IUPAC name | 1-[4-ethoxy-3-(6,7-dihydro-1-methyl-7-oxo-3-propyl-1H-pyrazolo[4,3-d]pyrimidin-5-yl)phenylsulfonyl]-4-methylpiperazine |
| Tradename | Viagra, Revatio, others |
| Drugs.com | Monograph |
| MedlinePlus | a699015 |
| Licence US | Viagra |
| Pregnancy AU | B1 |
| Routes of administration | By mouth, sublingual |
| CAS number | 139755-83-2 |
| PubChem | 5212 |
| DrugBank | DB00203 |
| ChemSpiderID | 5023 |
| UNII | BW9B0ZE037 |
| KEGG | D00485 |
| ChEBI | 8905 |
| ChEMBL | 192 |
| ATC prefix | G04 |
| ATC suffix | BE03 |
| Legal status | Prescription only |
| Bioavailability | ~40% |
| Protein bound | 96% |
| Metabolism | Liver (CYP3A4, CYP2C9) |
| Elimination half-life | 3–4 hours |
| Excretion | Feces (80%), urine (13%) |
sildenafil. It is a medication primarily used to treat erectile dysfunction and pulmonary arterial hypertension. Developed by the pharmaceutical company Pfizer, it was the first oral therapy approved for erectile dysfunction in the United States. Its mechanism involves inhibiting the enzyme phosphodiesterase type 5, leading to increased blood flow in specific tissues.
sildenafil is indicated for the management of erectile dysfunction, facilitating improved blood flow to the corpus cavernosum during sexual stimulation. Under the brand name Revatio, it is also approved for treating pulmonary arterial hypertension, a condition affecting the arteries of the lungs and the right side of the heart. Clinical studies, such as those published in the New England Journal of Medicine, have demonstrated its efficacy in improving exercise capacity in patients with this cardiovascular disorder. It is sometimes used off-label for altitude-related conditions, as researched by institutions like the University of Giessen.
Common adverse effects include headache, flushing, dyspepsia, and visual disturbances such as a blue-tinge to vision. More serious potential effects involve hypotension, sudden hearing loss, and priapism, a prolonged and painful erection requiring urgent medical attention. The Food and Drug Administration has issued warnings regarding the risk of vision loss from non-arteritic anterior ischemic optic neuropathy. Concurrent use with nitrates, commonly prescribed for angina pectoris, is contraindicated due to the risk of severe hypotension.
sildenafil acts as a selective inhibitor of the enzyme phosphodiesterase type 5, which degrades cyclic guanosine monophosphate in smooth muscle cells. This inhibition potentiates the vasodilatory effects of nitric oxide, leading to relaxation of smooth muscle in the corpus cavernosum and pulmonary vasculature. It is metabolized primarily by the hepatic cytochrome P450 isoforms CYP3A4 and CYP2C9. The major metabolite, formed by N-desmethylation, possesses about 50% of the parent drug's activity.
sildenafil was originally synthesized by a team of chemists at Pfizer's research facility in Sandwich, Kent, led by scientists including Peter Dunn and Albert Wood. Initially investigated as a potential treatment for hypertension and angina pectoris during the 1980s, its effects on penile erection were discovered serendipitously during clinical trials. The Food and Drug Administration approved it for erectile dysfunction in 1998, following a review process that included advisory committee meetings. Its subsequent approval for pulmonary arterial hypertension came in 2005.
The introduction of sildenafil, marketed as Viagra, had a profound social impact, significantly destigmatizing discussions about erectile dysfunction in media and popular culture. It became one of the most commercially successful drugs in history, generating billions in revenue for Pfizer. Its popularity led to issues with counterfeit drugs and illegal online sales, prompting actions from agencies like the World Health Organization and Interpol. The drug has been referenced extensively in films, television shows, and music, and its active ingredient is listed on the World Health Organization's List of Essential Medicines.